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Inflammation in periodontal disease is characterized by
the breakdown of the extracellular matrix. This study
shows that an inflammation-associated matrix break-
down fragment of fibronectin (FN) induces anoikis of hu-
man periodontal ligament (PDL) cells. This 40 kDa frag-
ment was identified in human inflammatory crevicular
fluid and is associated with disease status. Previously,
we reported that a similar recombinant FN fragment trig-
gered apoptosis of PDL cells by an alternate apoptotic
signaling pathway that requires transcriptional downreg-
ulation of p53 and c-myc. Thus, to determine whether the
physiologically relevant 40 kDa fragment triggers apop-
tosis in these cells, the 40 kDa fragment was generated
and studied for its apoptotic properties. The 40 kDa frag-
ment induces apoptosis of PDL cells, and preincubation
of cells with intact vitronectin, FN, and to a limited ex-
tent collagen I, rescue this apoptotic phenotype. These
data suggest that the 40 kDa fragment prevents PDL cell
spreading, thereby inducing anoikis. The signaling path-
way also involves a downregulation in p53 and c-myc, as
determined by Western blotting and real time quantita-
tive PCR. These data indicate that an altered FN matrix as
is elaborated in inflammation induces anoikis of resident
cells and thus may contribute to disease progression.
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Introduction
Altered FN matrices, as those elaborated during peri-
odontal disease or inflammation compromise PDL cell
or resident cell function. During the course of inflam-
mation, bacterial and host-derived proteases cleave the
extracellular matrix (ECM) and release fragments, includ-
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ing FN fragments, into the inflammatory milieu. We
have shown that these fragments negatively influence PDL
cell function by limiting their proliferative capacity and
chemotaxis, and by inducing programmed cell death or
apoptosis.1–3 Specific FN fragments also induce the ex-
pression of matrix degrading enzymes in these cells that
can further perpetuate the breakdown of the ECM compo-
nents and contribute to disease progression.4 Thus altered
FN matrices trigger altered cellular responses that are not
normally induced by intact FN. Exactly how these altered
matrices of FN mediate such a diverse repertoire of cell
functions is not fully understood. However, these effects
likely depend on the different specific ligand-receptor in-
teractions that take place in different cell types with dif-
ferent functional domains of FN, and on the subsequent
complex signaling mechanisms induced by these receptor-
mediated actions. Thus, in the present study we focused on
examining the role of the 40 kDa inflammation-associated
FN fragment in potentially altering PDL cell behavior and
the potential mechanisms involved. The rationale for ex-
amining this 40 kDa fragment is that it is similar to a
recombinant FN fragment (V+H− ) that we previously
showed induces apoptosis of PDL cells via a novel sig-
naling pathway.2,3 The similarity between the 40 kDa
fragment and the V+H− fragment stems from the fact
that they are both missing either part of the V region or
have a nonfunctional heparin-binding domain of FN; both
of which are critical for the regulation of cell survival.2
Thus, the 40 kDa fragment only has the CS-1 site of the
V region and the V+H− fragment has a mutated and
non-functional heparin-binding domain.
Since the 40 kDa fragment (Figure 1) contains the
heparin-binding domain and the CS-1 site of the alter-
natively spliced V region of FN, it can potentially bind
to cells using the α4β1 integrin and proteoglycan recep-
tors as discussed below. There may also be cooperative in-
teractions between these two classes of receptors. Indeed,
there is evidence of interactions between integrins and cell
surface chondroitin sulfate proteoglycan receptors.5,6 We
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Figure 1. Intact FN monomer (top) and recombinant (middle) and proteolytic (bottom) FN proteins. Both recombinant FN proteins span
repeats III10–15. They contain the V region (V+) and one protein also contains a functional heparin-binding domain (H+), whereas
the other protein has a mutated heparin-binding domain (H− ). The arginine, glycine, aspartic acid (RGD) cell-binding site (+) and the
heparin-binding sequence (*) are indicated within the clear boxes. Alternatively spliced repeats (EIIIB, EIIIA, V) are shaded. Type I–III
repeating modules are indicated in the key. The proteolytic, chymotryptic 40-kDa FN fragment is shown on the bottom. It contains the
heparin-binding domain and the CS-1 site of the V region of FN.
have specifically identified the α4, α5, αv, and β1 integrin
subunits on the surface of PDL cells, using fluorescence-
activated cell sorting (FACS) analysis on at least five dif-
ferent PDL cell isolates.1 The FACS data reveal that rel-
atively more αv is present on these cells than any of the
other three integrin subunits. The α5 and β1 subunits are
the next most abundant, and the α4 subunit is the least
abundant. In the case of the V+H− fragment, α5, αv,
α4, and β1 can bind to the RGD site on repeat III-10,7–9
and α4 and β1 can further bind to the V region (REDV
or LDV sites; 10) and the high-affinity heparin-binding
domain (IADPS on repeat III-14; 11) on the V+H− pro-
tein. Indeed, our published studies (2) with the V+H−
fragment suggest that integrins, and specifically, integrins
α4β1, may be mediating this apoptotic phenotype.
Evidence for the role of proteoglycans in mediating 40
kDa and V+H− fragment–mediated apoptosis is pro-
vided by our earlier studies.2 These data demonstrate that
treating cells with chondroitinase or chondroitin sulfate,
but not other glycosaminoglycans reversed the apoptotic
phenotype induced by the V+H− fragment. Candidate
chondroitin sulfate proteoglycan receptors include CD44
(and its isoforms), which binds the high-affinity heparin-
binding domain of FN on repeat III-14 (synthetic pep-
tide FN-C/H II, 6), and a chondroitin sulfate/heparan sul-
fate proteoglycan, like the syndecans, which also bind the
high-affinity heparin-binding domain of FN.12 Another
strong candidate is the NG2 chondroitin sulfate proteo-
glycan, which can cooperate with the α4β1 integrin in
binding to the V region and heparin-binding domain of
FN.13,14
In our previous studies with the V+H− recombinant
FN protein, the signaling mechanism by which this apop-
totic mechanism is triggered is novel and requires the
transcriptional downregulation of the tumor suppressor,
p53 and oncogene, c-myc.3 Upstream of p53, decreases
in focal adhesion kinase phosphorylation and increases in
c-Jun N-terminal kinase (JNK)1 phosphorylation further
regulate this pathway.15 JNKs are a group of MAP ki-
nases that are activated by cytokines or environmental
stress and are involved in various signaling pathways in-
cluding those for apoptosis. JNK proteins are activated by
phosphorylation and they directly associate with and reg-
ulate p53.16–18 Thus, in this study we examined whether
the physiologically relevant, inflammation-associated 40
kDa FN fragment possesses pro-apoptotic characteristics




Primary PDL cells were harvested as previously described4
and used from passages 2 to 6 for all experiments.
Culture medium consisted of alpha-minimal essential
medium supplemented with 10% fetal bovine serum,
and 1% penicillin/streptomycin. For experimentation,
cells were trypsinized, pelleted under centrifugation,
washed twice with phosphate-buffered saline, and sus-
pended in assay medium (serum-free alpha-minimal es-
sential medium supplemented with 0.2% lactalbumin hy-
drolysate [Invitrogen Corporation, Carlsbad, CA] and 1%
penicillin/streptomycin).
Generation and purification of the 40 kDa
FN fragment
The 40 kDa FN fragment was prepared by digest-
ing 400 µl of human plasma FN with 2 µl of
α-chymotrypsin (Sigma-Aldrich, St. Louis, MO; 0.5%
stock reconstituted in distilled water) at 37◦C in a water
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bath for 1 h and 10 min. The reaction was stopped
by adding 2.3 mg/ml of Diphenylcarbamoyl Chloride
(Sigma-Aldrich). The 40 kDa fragment was subsequently
purified using heparin-sepharose affinity chromatog-
raphy, gel filtration chromatography, and dialysis, and
concentrated using lyophilization as described below. For
heparin-sepharose chromatography, the digested 400 µl
of plasma FN preparation and an equal volume of double
distilled pyrogen-free water were loaded on the column
and incubated at 4◦C for 1 h with gentle shaking.
After the flow through was collected, affinity-bound FN
fragments were eluted with 0.01 M NaCl/50 mM Tris
HCl (pH 7.0). Fourteen fractions were collected and
analyzed by SDS-PAGE and Coomassie Blue stain, to
select the fractions that contained a 40 kDa fragment.
All the fractions that contained a 40 kDa fragment were
further chromatographed on G-25 Sephadex gel filtration
columns to remove excess salt and to further purify the
40 kDa fragment. After the flow through was collected,
FN fragments were eluted from this column with a
1X phosphate buffered saline solution free of calcium
and magnesium ions. Another fourteen fractions were
collected and screened again by SDS-PAGE to select
for those that contained a 40 kDa fragment. Fractions
containing a 40 kDa fragment were then pooled and
dialyzed against pyrogen-free water at 4◦C overnight
in a 10,000 molecular weight cutoff dialysis cassette
(Slide-A-Lyzer, Pierce, Rockford, IL). The dialyzed
sample was concentrated by lyophilization, and the
protein concentration was determined using the BCA kit
(Pierce). Positive identification of the 40 kDa fragment
was performed by Western blotting as described below.
Western immunoblotting
Western immunoblotting was used to confirm the pres-
ence of the purified 40 kDa fragment protein. 5 µg of
the 40 kDa fragment sample and media control were
electrophoretically resolved on 10% SDS-PAGE gels and
transferred to nitrocellulose membranes for Western im-
munoblotting. The membranes were probed with a mouse
anti-human FN antibody against the CS-1 site (MAB
1939, Chemicon Intl., City; used at a dilution of 1:200)
and a mouse anti-human FN antibody against the heparin
binding-domain (MAB 1938, Chemicon Intl; used at a di-
lution of 1:200). Membranes were then probed with an
anti-mouse horseradish peroxidase-conjugated secondary
antibody (1:2000) for 45 min at room temperature fol-
lowed by ECL detection (Amersham).
Recombinant FN fragment
Two recombinant FN protein fragments were tested
in these experiments. These fragments, described
elsewhere,19 included (V+) the alternatively spliced V
region and contained either an unmutated (H+) or
a mutated, nonfunctional high-affinity heparin-binding
domain (H− ).
Apoptosis assessment
Apoptosis in PDL cells was evaluated by three criteria:
(1) cell rounding plus membrane blebbing, (2) nuclear
disintegration, and (3) DNA fragmentation.
To evaluate cell rounding and membrane blebbing after
incubation under test and control conditions, cells were
visualized, counted, and photographed at 400X magni-
fication using an inverted microscope equipped with an
automatic camera.
To assess the quality of the nucleus, PDL cells were in-
cubated with the 40 kDa protein fragment (1 mg/ml) and
the recombinant FN protein, V+H− (0.1 µM) or with
control assay medium for 14 h in 16-well glass cham-
ber slides, and nuclear staining of DNA was used to de-
tect nuclear disintegration. Specifically, after incubation
under test and control conditions, cells were fixed with
ice-cold 100% methanol for 15 min, stained with a fluo-
rescent groove-binding probe for DNA, 4’,6-diamidino-
2-phenylindole (DAPI, Sigma-Aldrich) for 10 min, rinsed
three times with calcium- and magnesium-free PBS,
dried, and sealed with a coverslip, using mounting
medium (Vectashield; Vector Laboratories, Burlingame,
CA). Cells were counted and photographed at 400x mag-
nification using a fluorescent photomicroscope equipped
with a camera and filter for DAPI stain detection (Nikon
E400 microscope). Condensed, brightly stained and dis-
integrated nuclei were counted as positive. An average of
five fields from triplicate wells were counted.
Immobilized/coated and soluble FN fragments
and ECM ligands
In experiments testing whether the effects of the 40 kDa
fragment were dependent on its presentation as a solu-
ble or immobilized matrix, the 40 kDa fragment (0.5
mg/ml), the V+H− fragment (0.1 µM), and a serum-
free media control were coated overnight at 4◦C on 16-
well chamber slides to immobilize these molecules prior
to treatment with PDL cells. Plates were then washed 3x
with PBS/DPBS. Subsequently, cells were added to the
wells and either not treated further (coated conditions) or
treated with the 40 kDa fragment (1 mg/ml) and V+H−
fragment (0.1 µM), and then cell shape and nuclear stain-
ing were examined after 14 h.
In experiments testing whether intact FN and other
ECM ligands could rescue the apoptotic phenotype trig-
gered by the 40 kDa fragment, intact human plasma
FN (1 mg/ml; Calbiochem, San Diego, CA), human
placenta collagen I (0.5 mg/ml; Chemicon International
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Temecula, CA), human plasma vitronectin (0.4 mg/ml;
Promega, Madison, WI) and an assay media control were
coated overnight at 4◦C on 16-well chamber slides as im-
mobilized forms of ECM prior to treatment with PDL
cells. Plates were then washed 3x with PBS/DPBS. Sub-
sequently, cells were treated with the 40 kDa fragment
(1 mg/ml) and cell shape and nuclear staining were exam-
ined after 14h. PDL cells were fixed, stained, and counted
as described above.
DNA fragmentation assessment
For a quantitative assessment of cell apoptosis, DNA
fragmentation in cell lysates and supernatants was as-
sayed after a 14 h incubation with the 40 kDa fragment
(0.5 mg/ml) and the recombinant FN protein, V+H−
(0.1 µM) or with control assay medium using the cell
death detection ELISA Plus Kit (Roche, 1774425, In-
dianapolis, IN). The ELISA, which measures cytoplas-
mic histone-associated DNA fragments after induced cell
death, was performed according to the manufacturer’s in-
structions. Colorimetric detection and quantification of
the ELISA was performed on a Vmax kinetic microplate
reader (Molecular Devices, Menlo Park, CA). Using rela-
tive units, total levels of DNA fragments were compared
for all treatments.
Real-time quantitative PCR
Real time quantitative PCR was used to assess changes in
p53 and c-myc levels triggered by the 40 kDa fragment.
For this purpose, PDL cells were plated in 200 µl of assay
medium at a density of 5.0 × 105 cells/well in a 24-well
plate. Subsequently, cells were treated with the 40 kDa
protein fragment (1 mg/ml) and the V+H− fragment
(0.1 µM) or with control assay media for 7 h. Cells were
then collected by scraping, washed twice in PBS, and lysed
in RLT buffer (proprietary lysis buffer, Qiagen, Valencia,
CA). Total RNA was extracted using the RNAeasy kit
(Qiagen), according to the manufacturer’s instructions.
The concentration of RNA in the samples was ascertained
by measuring optical density at 260 nm.





GAPDH TET 5′ -CAA GCT TCC CGT TCT CAG CC-3′
P53 FAM 5′ -TTG GCT CTG ACT GTA CCA CCA TCC AC-3′
c-myc FAM 5′ -CCA GGA CTG TAT GTG GAG CGG CTT CT-3′
F: forward primer; R: reverse primer.
Total RNA from each sample was used to generate
cDNA using an iScript cDNA synthesis kit (Bio-Rad,
170-8890, CA) according to the manufacturer’s protocol.
Briefly, 1 µg of total RNA was used as starting material for
each sample, to which 4 µl of 5x iScript reaction mix, 1 µl
of iScript reverse transcriptase, and nuclease-free water
were added to a final volume of 20 µl. Reactions were
carried out at 25◦C for 5 min, 42◦C for 30 min, and
85◦C for 5 mins.
The primers and probes used for the housekeeping
gene, GAPDH, and human p53 genes were purchased
from Biosource Inc. (Camarillo, CA). The primer and
probe for c-myc were obtained from the UCSF Genome
Analysis Core Facility (UCSF, Comprehensive Cancer
Center) as a gift. The sequences of primer/probes are listed
in Table 1.
All assays were performed using the ABI 7700 sequence
detection system (Applied Biosystems, Foster City, CA).
Each assay was performed separately. In brief, 100 ng of
extracted DNA, control DNA or water (with no template
control), 5 µl of a 10x forward and reverse primer mix-
ture, and 1 µl of 50x probe were added to a 1x master mix
(5x TM buffer, 25 mM MgCl2, 25 mM dNTP and water;
master mix obtained from the UCSF Genome Analysis
Core Facility of the UCSF Comprehensive Cancer Center)
in a final volume of 50 µl. The RT-PCR reaction condi-
tions used were 10 min at 95◦C as an initial polymerase
activation step, followed by 40 amplification cycles of 15
s at 95◦C, and a cycle for 1 min at 60◦C.
To quantitate the relative amount of gene expression
for both the target and housekeeping gene, the com-
parative CT (threshold cycle) method was used. The
corresponding arithmetic formulas used are the follow-
ing: CT = CTtarget gene − CTGAPDH; and CTLinear =
2− (CTtreated−CTcontrol). CTLinear represents the fold
change in mRNA expression between the control and
treated groups, and assumes a doubling of target sequence
with each PCR cycle. The mRNA transcript level was
normalized against GAPDH at each dilution. Percentage
expression of p53 and c-myc were normalized and com-
pared with GAPDH. The comparative CT method was
used as outlined in User Bulletin #2 (Applied Biosystems).
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Figure 2. Western blots illustrate the presence of the 40 kDa fi-
bronectin fragment present in human gingival crevicular fluid from
healthy (H), moderate periodontitits (MP), and severe periodonitits
(SP) sites. The same 40 kDa that induces apoptosis in vitro is
found in the most diseased sites. Blots were developed with ECL
Plus (Amersham). The 40-kDa chymotryptic fragment was loaded
as a positive control (40). Blots were probed with antibodies to the
heparin-binding domain of fibronectin (MAB 1938, Chemicon) in
A and the CS-1 site of fibronectin (MAB 1939, Chemicon) in B.
Briefly, this comparative CT method involved averaging
triplicate samples, which were taken as the CT-values for
p53, c-myc and GAPDH. The  CT-value was obtained
by subtracting the average GAPDH CT-values from the
Figure 3. These series of gels and Western blots illustrate the steps involved in the purification scheme for the 40 kDa FN fragment. A.
This is a Coomassie Blue stained gel of plasma fibronectin (FN) digested with α- chymotrypsin and column fractions of this preparation
after affinity chromatography on Heparin-Sepharose (HS) and elution with 0.01 M NaCl/50 mM Tris-HCl (pH 7.0). The starting material
(second lane on the left) is plasma fibronectin digested with α- chymotrypsin (FN/α-chy). The flow through (FT) represents the unbound
material. Fractions 1 through 3 represent the bound material eluted from the column. B. This is a Coomassie Blue stained gel of column
fractions from a G-25 Sephadex gel filtration column containing the 40 kDa α-chymotryptic FN fragment. Column fractions 1 and 2 from
the Heparin-Sepharose column in Figure A were used as the starting material. The column fractions were eluted with double-distilled
pyrogen free water. C. This is a Coomassie Blue stained gel of the concentrated and dialyzed G-25 fractions 3 and 4 (in Figure B)
containing the 40 kDa fragment. D. This Western immunoblot illustrates the presence of the 40 kDa fragment (CS-1 reactive band) in
the purified and concentrated sample in Figure C (third lane on the right). E. This Western immunoblot illustrates the presence of the 40
kDa fragment (heparin-binding domain [HD] reactive band) in the purified and concentrated sample in Figure C.
average CT-values of p53 and c-myc. The fold change
was calculated according to the formula 2− (CT), where
CT was the difference between CT and CT value.
The level of gene expression for the control group was
arbitrarily set at 1 to serve as a reference. Therefore, the
expression of the target gene from experimental groups
represents the fold-difference expression relative to the
reference control gene.
Results
We previously showed that disease associated FN frag-
ments, including the 40 kDa fragment are associated with
periodontal disease status.20 The 40 kDa fragment, which
contains the N-terminal heparin-binding domain and CS-
1 site of the V region of FN was identified at sites of severe
periodontitis and it was found in high levels at these sites
compared to sites with moderate disease or healthy sites
(Figure 2). Furthermore, since, we previously determined
that a recombinant FN protein with similar FN domains
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as those in the 40 kDa fragment induces PDL cell apopto-
sis, we hypothesized that the physiologically relevant 40
kDa fragment might also trigger apoptosis in these cells.
To examine this possibility, we first generated, purified,
and positively identified the 40 kDa fragment from intact
plasma FN (Figure 3) using various purification schemes
that included heparin sepharose affinity chromatography,
G-25 Sephadex gel filtration chromatography, dialysis,
and lyophilization.
Having generated the 40 kDa fragment (Figure 3), the
fragment was subsequently incubated with PDL cells to
determine whether it had any proapoptotic properties.
Indeed, similar to the V+H− recombinant FN frag-
ment, the 40 kDa fragment induced PDL cell rounding,
membrane blebbing, nuclear condensation, and high lev-
Figure 4. Effect of the 40 kDa chymotryptic fragment of FN on PDL cell apoptosis. A. PDL cells plated in the presence of the 40 kDa
fragment (0.5 mg/ml) or positive control fragments V+H− (0.1 µM) are rounded (Phase) and have DAPI-stained nuclei that are bright
and condensed by 14 h after treatment. This is in contrast to the negative controls, PDL cells plated in media alone or with the V+H+
fragment, which spread (Phase) and have normal, oval-shaped nuclei (DAPI). B. ELISA for DNA fragments indicates high levels of DNA
fragmentation in PDL cell lysates and supernatants from cells treated with the 40 kDa fragment (0.5 mg/ml) and the V+H− (0.1 µM)
FN protein compared to media (c) and V+H+ (0.1 µM) controls.
els of DNA fragmenation; all characteristic of apoptosis
(Figure 4). Cells incubated in control media or with the
control recombinant FN fragment, V+H+, did not ex-
hibit this phenotype, and instead were well spread with
oval shaped nuclei, and had low levels of DNA fragmen-
tation (Figure 4).
To determine whether the effects of the 40 kDa frag-
ment were dependent on its presentation as a soluble ma-
trix or whether an immobilized 40 kDa fragment could
also induce apoptosis, cells were incubated with both sol-
uble and immobilized forms of the 40 kDa fragment
(Figure 5). Only the soluble form of the 40 kDa fragment
induced the apoptotic phenotype in these cells. Similarly,
only the soluble form of the positive control V+H−
fragment induced the apoptotic phenotype, whereas the
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Figure 5. Effect of soluble and coated forms of the 40 kDa chymotryptic fragment of FN on PDL cell apoptosis. A. PDL cells plated in
the presence of soluble forms of the 40 kDa fragment (0.5 mg/ml) or positive control fragments V+H− (0.1 µM) are rounded (Phase)
and have DAPI-stained nuclei that are bright and condensed by 14 h after treatment. In contrast, cells plated in the presence of coated
forms of the 40 kDa or V+H− fragment, spread (Phase) and have normal, oval shaped nuclei (DAPI), like the controls.
immobilized forms of the FN fragments did not. Control
conditions mirrored those of the immobilized fragment-
treated cells. Thus, these findings suggest that the 40 kDa
fragment in solution prevents cell spreading and thereby
triggers anoikis. Anoikis is defined as apoptosis triggered
by detachment from the ECM or inability to attach to the
ECM.
Given these findings, we next examined whether allow-
ing cells to spread first in the presence of various intact
ECM ligands would protect cells from apoptosis triggered
by the soluble 40 kDa fragment. Indeed, the data demon-
strate that cells allowed to spread on intact vitronectin
were most resistant to apoptosis triggered by the 40 kDa
fragment, followed by cells allowed to spread on intact
FN and then by collagen I (Figure 6). These findings con-
firm that FN fragments induce anoikis in cells deprived
of contacts with their ECM. In this context, since vit-
ronectin provided the most rescue potential in these cells
compared to the other ECM ligands examined, its recep-
tors or associated survival signals may be key regulators
in this mechanism.
The signaling mechanisms involved in this pathway
of anoikis triggered by the 40 kDa fragment may be the
same as those previously identified in our studies with
the V+H− recombinant fragment.2,3,21 These previous
studies demonstrated that the V+H− FN fragment trig-
gers apoptosis of PDL cells by transcriptionally down-
regulating p53 and c-myc and inducing increased JNK
phosphorylation (pJNK). Thus, in the current study the
levels of p53, c-myc, and pJNK were examined in 40
kDa fragment treated cells by Western blot analyses and
quantitative real time PCR. These data show that p53 and
c-myc levels are also downregulated and pJNK levels are
upregulated by treatment with the 40 kDa fragment as
in V+H− fragment treated cells (Figure 7).
Discussion
This study documents for the first time that disease as-
sociated matrix fragments of fibronectin induce anoikis
in human primary cells. The mechanism by which this
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Figure 6. Effect of different extracellular matrices on 40 kDa-mediated apoptosis. A. The graph illustrates the percent rescue from
40 kDa-mediated apoptosis by pretreatment with intact FN, collagen I, vitronectin, and control media. B. Images of cells under Phase
microscopy and after DAPI staining illustrate the cell shape and nuclear profile of cells preincubated with intact FN, collagen I, vitronectin,
and control media then treated with the 40 kDa fragment or treated with no fragment and incubated in media alone.
occurs appears to be comparable to that induced by a
similar recombinant FN fragment that was previously
shown to induce apoptosis of PDL cells by transcription-
ally downregulating c-myc and p533 and increasing JNK
phosphorylation.15 The 40 kDa fragment also induced
decreases in p53 and c-myc and increases in JNK phos-
phorylation. The implications from these findings is that
during the course of inflammation, degradation of ma-
trix molecules may further contribute to disease progres-
sion by induction of programmed cell death in resident
cells.
Figure 4 indicates that the 40 kDa FN fragment in-
duces higher levels of DNA fragmentation compared to
the V+H− recombinant protein. The reason for this
difference stems from the fact that the concentration
of the 40 kDa fragment used (0.5 mg/ml) in this ex-
periment is higher than that of the V+H− fragment
(0.00825 mg/ml). The rationale for using these concen-
trations is that our initial work with the V+H− frag-
ment indicated that this was the lowest concentration that
induced apoptosis in cells. In contrast, a higher concen-
tration of the 40 kDa fragment was required to induce
apoptosis in vitro. Furthermore, in vivo data indicated that
the physiologic concentration of the 40 kDa fragment
in inflammatory fluids20 was approximately equivalent to
the 0.5 mg/ml tested in vitro. Thus, all subsequent ex-
periments were performed with similar concentrations of
these fragments to assess apoptosis. Based on these find-
ings, the V+H− appears to be more efficient at induc-
ing apoptosis than the 40 kDa fragment. The reason for
this is not known although it may be related to struc-
tural differences in the proteolytically-generated 40 kDa
fragment and the recombinantly derived V+H− protein.
More specifically, these differences may be related to three-
dimensional structural variations or sequence differences
in these fragments that, in turn, interact differently with
and have different binding affinities for the cell surface re-
ceptors that regulate this apoptotic mechanism and DNA
fragmentation.
Finding that only the soluble forms of the FN frag-
ments induced apoptosis in these cells suggests that the
apoptotic effects of the fragments are related to their
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Figure 7. Expression levels of p53, c-myc, and pJNK in PDL cells treated with FN fragments. A. These Western immunoblots illustrate
the changes in p53, pJNK, and c-myc levels in PDL cells treated with the 40 kDa FN fragment, recombinant V+H− FN fragment, or
media control. Actin was used as a loading control. B. Graphs illustrate the percent expression of p53 and c-myc in FN fragment treated
cells as assessed by realtime quantitative PCR.
effects on cell spreading. The fragments may be inducing a
unique form of apoptosis, called anoikis, which is defined
as programmed cell death triggered by detachment from
the extracellular matrix (ECM) or inability to attach to
the ECM. Previous studies have shown that cells deprived
of an ECM undergo anoikis.22 In the current study, the
soluble FN fragments may in their interactions with cells
block the necessary receptors required for anchoring the
cells to the ECM. However, the coated fragments allow
cells to attach via other mechanisms that may include de
novo secretion of their own matrix or only partial block-
ing of the receptors required for anchoring. Our previous
studies indicate that receptors including integrins and a
chondroitin sulfate proteoglycan may be mediating in-
teractions with these fragments of FN2 to regulate this
apoptotic mechanism.
In further support of the idea that the 40 kDa fragment
may be triggering anoikis in these cells, is the rescue data
with intact ECM proteins, including vitronectin. These
data show that allowing PDL cells to spread on ECM
components first, prevents the induction of apoptosis by
subsequent introduction of the soluble 40 kDa fragment.
Thus, cells that have already spread are no longer respon-
sive to the proapoptotic effects of the fragment.
Additionally, the rescue data with the intact ECM com-
ponents shows that cells that spread on vitronectin are
more resistant to the effects of the soluble 40 kDa frag-
ment. These findings suggest that either the receptors
used by the 40 kDa fragment are most like those for vit-
ronectin, the alpha v beta 1 integrin for example, or that
the survival signals generated by vitronectin are more
complete that those induced by other intact ECM pro-
teins, like fibronectin or collagen. The former presents an
interesting possibility; that the alpha v beta 1 integrin is
mediating interactions with the 40 kDa fragment of FN.
However, the alpha v beta 1 integrin has been shown to
interact only with the RGD site of FN8, but not with
the heparin-binding domain or CS-1 site of FN that are
present on the 40 kDa fragment. Thus, further studies
will focus on the interesting possibility that the alpha v
beta 1 integrin also interacts with the heparin-binding
domain and/or CS-1 site of FN.
The downregulation in p53 and c-myc mRNA lev-
els induced by the 40 kDa fragment is more pronounced
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than that induced by the V+H− recombinant protein,
and this is in contrast to that noted for the downregulation
in p53 and c-myc protein levels. One likely explanation
for this difference is that the 40 kDa fragment may have
more of an effect on transcriptional and translational con-
trol, thus explaining the greater effects on mRNA levels,
and the V+H− protein may be exhibiting more post-
translational effects (i.e. proteasomal degradation), thus
also explaining its greater effects at the protein level.
Conclusion
Our results demonstrate that matrix breakdown frag-
ments of FN that are produced during inflammation in-
duce anoikis of primary resident PDL cells, and thereby
may contribute to disease progression.
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